Dr. Tom Waddell completed his undergraduate training at Glasgow University in 2003 and completed his UK General Medical Training (MRCP) in 2007. In August 2007 Tom moved to Manchester for a 1-year post as an oncology research fellow in the HPB and colorectal unit at the Christie Hospital. This post helped to develop his interest in oncology, and in 2008 he commenced a 4-year training post as a Medical Oncology SpR at the Royal Marsden Hospital, London. During his training he also completed an MD(Res) degree in gastro-oesophageal cancer at the University of London.

In October 2016, following completion of his training, Tom returned to the Christie Hospital to continue his career as a Consultant Medical Oncologist. In his current post he treats patients with both gastro-oesophageal and renal malignancies, with a particular clinical and research interest in the use of immunotherapies to treat renal cancer. He holds PI and CI roles on several national and international trials in renal cancer and is the Renal Cancer Lead at the Christie Hospital. In June 2020, Dr Waddell was appointed as the Chairman of the UK NCRI Renal Systemic Treatment Subgroup – and he continues to lead the subgroup with charitable support from Action Kidney Cancer following the closure of the NCRI.